Viewing Study NCT05619367

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-02-01 @ 10:32 AM
Study NCT ID: NCT05619367
Status: AVAILABLE
Last Update Posted: 2025-12-23
First Post: 2022-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Compassionate Use (CU) Program of Odronextamab
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory (R/R) Follicular Lymphoma (FL) View
None Diffuse Large B-Cell Lymphoma (DLBCL) View
None B-Cell Non-Hodgkin Lymphoma (NHL) View
None High-Grade B-Cell Lymphoma (HGBCL) View
Keywords: